1. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma
    Zhujuan Wang et al, 2020, Cell Cycle CrossRef
  2. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1
    Meiling Li et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  3. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma
    Dan Wang et al, 2018, Bioscience Reports CrossRef
  4. Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p
    Zhiqin Li et al, 2019, Cancer Cell International CrossRef
  5. MicroRNA-362-3p Inhibits Migration and Invasion via Targeting BCAP31 in Cervical Cancer
    Shuya Yang et al, 2020, Frontiers in Molecular Biosciences CrossRef
  6. The suppressive role of miR-362-3p in epithelial ovarian cancer
    Jialing Yuan et al, 2020, Heliyon CrossRef
  7. miR-362-3p regulates cell proliferation, migration and invasion of trophoblastic cells under hypoxia through targeting Pax3
    Nan Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  8. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR‐362‐5p/Nf‐κB axis
    Liang Zhao et al, 2018, Journal of Cellular Physiology CrossRef
  9. MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer
    Jin'e Wan et al, 2019, Yonsei Medical Journal CrossRef
  10. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
    Jonathan Xu et al, 2022, Urologic Cancers CrossRef
  11. Milk fat miRNome changes in response to LPS challenge in Holstein cows
    Christine Leroux et al, 2023, Veterinary Research CrossRef
  12. MiR-411 Functions as a Tumor Suppressor in Renal Cell Cancer
    Xintao Zhang et al, 2017, The International Journal of Biological Markers CrossRef
  13. miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
    Shujun Cao et al, 2021, Journal of Ovarian Research CrossRef
  14. miR-362-3p suppresses ovarian cancer by inhibiting LRP8
    Chun Li et al, 2022, Translational Oncology CrossRef
  15. Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice
    Alberto Izzotti et al, 2016, Oncotarget CrossRef
  16. Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical Biomarkers
    Dominik A. Barth et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  17. MiR‐362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway
    Shuya Yang et al, 2021, Cancer Medicine CrossRef
  18. A novel microRNA signature for the detection of melanoma by liquid biopsy
    Claudia Sabato et al, 2022, Journal of Translational Medicine CrossRef
  19. Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
    Guiyun Cheng et al, 2020, Frontiers in Oncology CrossRef
  20. microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1
    Junbo Rong et al, 2021, Cell Cycle CrossRef
  21. Aberrant miR-362-3p is Associated with EBV-Infection and Prognosis in Nasopharyngeal Carcinoma and Involved in Tumor Progression by Targeting JMJD2A
    Xiangyun Wang et al, 2022, OncoTargets and Therapy CrossRef
  22. miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis
    Lu Jin et al, 2017, Oncology Letters CrossRef
  23. MicroRNA‐329‐mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma
    Zhi‐Gao Hu et al, 2019, Journal of Cellular Biochemistry CrossRef